[1] Li H, Liu R, Li J, et al. Tumor location influences perioperative and oncologic outcomes in solitary intrahepatic cholangiocarcinoma following curative resection: A multi-center analysis[J]. HPB (Oxford),2022,4(9):1543-1550. [2] Lopez-Lopez V, Robles-Campos R. ASO Author Reflections: Extreme Liver Surgery for Intrahepatic Cholangiocarcinoma: To be or Not to be Resected, that is the Question[J]. Ann Surg Oncol,2023,30(2):766-767. [3] 胡婧怡, 周华邦, 刘文迪, 等. 肝内胆管细胞癌与肝细胞癌临床特征及预后的比较研究[J]. 中华肝脏病杂志,2019,27(7):511-515. [4] Zhang M, Liu Y, Han L, et al. Application Value of Contrast-Enhanced Ultrasound Combined with Enhanced MR Scanning in Patients with Intrahepatic Cholangiocarcinoma[J]. J Healthc Eng, 2022,2022(8):e6402646. [5] Van D, Mcinnes M, Salameh J P, et al. CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis[J]. Radiology,2022,302(2):326-335. [6] Ali H, Tedder B, Waqar S H, et al. Changing incidence and survival of intrahepatic cholangiocarcinoma based on Surveillance, Epidemiology, and End Results Database (2000-2017)[J]. Ann Hepatobiliary Pancreat Surg,2022,26(3):235-243. [7] Geyer T, Rübenthaler J, Marschner C, et al. Structured Reporting Using CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma (HCC)—Impact and Advantages on Report Integrity, Quality and Interdisciplinary Communication[J]. Cancers (Basel),2021,13(3):534-537. [8] Guo HL, Zheng X, Cheng MQ, et al. Contrast-Enhanced Ultrasound for Differentiation Between Poorly Differentiated Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma[J]. J Ultrasound Med,2022,41(5):1213-1225. [9] Wang X, Liang P, Yu J, et al. Contrast-enhanced ultrasound features predict the prognosis of percutaneous microwave ablation of intrahepatic cholangiocarcinoma[J]. Br J Radiol,2022,95(1133):e21379. [10] 陈凡, 陈春, 刘颖, 等. 超声造影参数联合声触诊组织量化技术对肝细胞癌及肝血管瘤的鉴别诊断价值[J]. 中国医学装备,2022,19(10):79-82. [11] 张少飞, 张凯, 土继政, 等. 肝内胆管细胞癌超声造影和增强CT增强特征的对比研究[J]. 中国临床医学影像杂志,2022,33(2):114-117. [12] Kurebayashi Y, Kubota N, Sakamoto M. Immune microenvironment of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and liver metastasis of colorectal adenocarcinoma: Relationship with histopathological and molecular classifications[J]. Hepatol Res,2021,51(1):5-18. [13] Zhou H, Zhang C, Du L, et al. Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Hepatocellular Carcinoma: Diagnostic Performance and Interobserver Agreement[J]. Ultraschall Med,2022,43(1):64-71. [14] 王晶, 张洁, 赵静. 超声造影联合声触诊组织量化技术鉴别肝血管瘤与肝细胞癌价值研究[J]. 实用肝脏病杂志,2022,25(4):575-578. [15] Sheng R, Huang X, Jin K, et al. Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinoma[J]. Eur Radiol,2022,32(8):5156-5165. [16] 洪德娜, 朱桂新, 张敬红, 等. 超声造影对胆管细胞癌与肝细胞癌的鉴别诊断价值[J]. 临床超声医学杂志,2021,23(9):679-683. [17] Chen Y, Zhu Y, Chen K, et al. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis[J]. Clin Hemorheol Microcirc,2021,79(2):293-309. [18] 叶显俊, 胡蕾, 何年安, 等. logistic回归模型评价常规超声及超声造影对 胆管细胞癌与肝细胞癌的鉴别诊断价值[J]. 临床肝胆病杂志,2019,35(11):2502-2507. [19] 周成. 增强CT与超声造影技术在肝脏小占位病变诊断中的临床价值比较[J]. 影像研究与医学应用,2021,005(017):116-117. [20] 周正, 刘玮. 肝血管瘤、肝细胞癌和肝血管平滑肌脂肪瘤超声造影特点观察[J]. 实用肝脏病杂志,2021,24(6):911-914. |